TransBiotec, Inc. releases salary data. CEO sees compensation fall -24%

TransBiotec, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2020, the company's CEO made 213,000.

The table is included below:






















































































































































































































































































































































































































































SUMMARY COMPENSATION TABLE







Name


and Principal


Position










Year










Salary




($)

(1)














Bonus




($)










Stock




Awards




($)










Option




Awards




($)

(9)














Non-Equity




Incentive




Plan




Compensa


tion




($)








Change in




Pension




Value and




Nonqualified




Deferred




Compensation


Earnings




($)










All




Other




Compensa


tion




($)













Total




($)







Kevin Moore,







2020









213,000








-0-







-0-







-0-










-0-







-0-








-0-












213,000





CEO

(2)(11)







2019









39,508








-0-







-0-









240,779








-0-







-0-








-0-












280,287




















































































David Gandini,







2020









185,000








-0-







-0-








-0-










-0-







-0-








-0-












185,000





CFO, CRO and Secretary

(3)







2019









29,417








-0-







-0-









215,018








-0-







-0-








-0-












244,435




















































































Dean Watson, CTO

(10)









2020









43,750








-0-







-0-








-0-










-0-







-0-








-0-












43,750




















































































Charles Bennington


















































































Former Chief Executive Officer,







2020









50,000


(5)






-0-







-0-








-0-










-0-







-0-








-0-












50,000


(5)



CFO, and Secretary

(4)







2019








-0-










-0-







-0-









4,163








-0-







-0-









60,000


(6)








64,163






















































































Nick Noceti, Former CFO

(7)







2020









16,500


(8)






-0-







-0-








-0-










-0-







-0-








-0-












16,500


(8)









2019








-0-










-0-







-0-









4,163








-0-







-0-









66,000


(8)








70,163


(8)


The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever TransBiotec, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

TransBiotec, Inc. director just picked up 11,765 shares - June 21, 2022
TransBiotec, Inc. director just declared ownership of no shares of TransBiotec, Inc. - June 15, 2022
TransBiotec, Inc.'s CFO just declared ownership of no shares of TransBiotec, Inc. - June 13, 2022
TransBiotec, Inc.'s CFO just picked up 11,765 shares - June 13, 2022

Auto Refresh

Feedback